Evidence map›Paper›PMID 32575727›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Crystallography, in Silico Studies, and In Vitro Antifungal Studies of 2,4,5 Trisubstituted 1,2,3-Triazole Analogues.

Katharigatta N Venugopala, Mohammed A Khedr, Yarabahally R Girish, Subhrajyoti Bhandary, Deepak Chopra, Mohamed A Morsy, Bandar E Aldhubiab, Pran Kishore Deb, Mahesh Attimarad, Anroop B Nair and 8 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 5 countries.

Katharigatta N VenugopalaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0003-0680-1549
Mohammed A KhedrDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-0385-9481
Yarabahally R GirishACU-Center for Research and Innovations, BGSIT Campus, Adichunchanagiri University, B.G. Nagara, Mandya District 571448, India.ORCID 0000-0001-6709-7159
Subhrajyoti BhandaryDepartment of Chemistry, Indian Institute of Science Education and Research Bhopal, Bhopal By-pass Road, Bhauri, Bhopal 462066, India.
Deepak ChopraDepartment of Chemistry, Indian Institute of Science Education and Research Bhopal, Bhopal By-pass Road, Bhauri, Bhopal 462066, India.ORCID 0000-0002-0018-6007
Mohamed A MorsyDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-6752-9094
Bandar E AldhubiabDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-2684-4186
Pran Kishore DebFaculty of Pharmacy, Philadelphia University, Amman 19392, Jordan.ORCID 0000-0002-8650-2874
Mahesh AttimaradDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-7007-9119
Anroop B NairDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0003-2850-8669
Nagaraja SreeharshaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Rashmi VDepartment of Public health Medicine, University of KwaZulu-Natal, Howard College Campus, Durban 4041, South Africa.ORCID 0000-0002-1101-4577
Mahmoud KandeelDepartment of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0003-3668-5147
Sabah H AkrawiDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Madhusudana Reddy M BDepartment of Chemistry, School of Applied Sciences, REVA University, Bangalore 560064, India.
Sheena ShashikanthDepartment of Studies in Organic Chemistry, University of Mysore, Manasagangotri, Mysore 570006, India.
Osama I AlwassilDepartment of Pharmaceutical Sciences, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia.ORCID 0000-0002-6572-8321
Viresh MohanlallDepartment of Biotechnology and Food Technology, Durban University of Technology, Durban 4001, South Africa.ORCID 0000-0002-0103-7089
King Faisal University · SADurban University of Technology · ZAIndian Institute of Science Education and Research, Bhopal · INKafrelsheikh University · EGKing Saud bin Abdulaziz University for Health Sciences · SAPhiladelphia University · JOREVA University · INUniversity of KwaZulu-Natal · ZAUniversity of Mysore · IN

Funding

Deanship of Scientific Research, King Faisal University Nasher Track Grant No. 186196
6 · The paper itself

Abstract

A series of 2,4,5 trisubstituted-1,2,3-triazole analogues have been screened for their antifungal activity against five fungal strains,

Indexed as

2,4,5 trisubstituted 1,2,3-triazolesantifungal activitydynamic studiesminimum inhibitory concentrationmolecular dockingsingle-crystal X-ray diffraction

Identifiers

PMID32575727
PMCPMC7344790
OpenAlexW3036476658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.